• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 在结直肠癌肝转移中的作用和治疗潜力。

The Role and Therapeutic Potential of miRNAs in Colorectal Liver Metastasis.

机构信息

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA.

出版信息

Sci Rep. 2019 Nov 1;9(1):15803. doi: 10.1038/s41598-019-52225-2.

DOI:10.1038/s41598-019-52225-2
PMID:31676795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6825151/
Abstract

Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide. Liver metastasis is the major cause of CRC patient mortality, occurring in 60% patients with no effective therapies. Although studies have indicated the role of miRNAs in CRC, an in-depth miRNA expression analysis is essential to identify clinically relevant miRNAs and understand their potential in targeting liver metastasis. Here we analyzed miRNA expressions in 405 patient tumors from publicly available colorectal cancer genome sequencing project database. Our analyses showed miR-132, miR-378f, miR-605 and miR-1976 to be the most significantly downregulated miRNAs in primary and CRC liver metastatic tissues, and CRC cell lines. Observations in CRC cell lines indicated that ectopic expressions of miR-378f, -605 and -1976 suppress CRC cell proliferation, anchorage independent growth, metastatic potential, and enhance apoptosis. Consistently, CRC patients with higher miR-378f and miR-1976 levels exhibited better survival. Together, our data suggests an anti-tumorigenic role of these miRNAs in CRC and warrant future in vivo evaluation of the molecules for developing biomarkers or novel therapeutic strategies.

摘要

结直肠癌(CRC)是全球癌症相关死亡的第四大主要原因。肝转移是 CRC 患者死亡的主要原因,在无有效治疗方法的患者中,60%发生肝转移。尽管研究表明 miRNA 在 CRC 中的作用,但深入的 miRNA 表达分析对于确定临床相关的 miRNA 并了解其在靶向肝转移中的潜力至关重要。在这里,我们分析了来自公开的结直肠癌基因组测序项目数据库的 405 名患者肿瘤中的 miRNA 表达。我们的分析表明,miR-132、miR-378f、miR-605 和 miR-1976 是原发性和 CRC 肝转移组织以及 CRC 细胞系中下调最显著的 miRNA。在 CRC 细胞系中的观察结果表明,miR-378f、-605 和 -1976 的异位表达可抑制 CRC 细胞的增殖、锚定非依赖性生长、转移潜能,并增强细胞凋亡。一致地,miR-378f 和 miR-1976 水平较高的 CRC 患者的生存情况更好。总之,我们的数据表明这些 miRNA 在 CRC 中具有抗肿瘤作用,需要进一步在体内评估这些分子,以开发生物标志物或新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/b61bb12a7640/41598_2019_52225_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/1ba12f993184/41598_2019_52225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/60dbd7e72dae/41598_2019_52225_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/e14f7f71dcb2/41598_2019_52225_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/38a62168f759/41598_2019_52225_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/31e38438dbb5/41598_2019_52225_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/b61bb12a7640/41598_2019_52225_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/1ba12f993184/41598_2019_52225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/60dbd7e72dae/41598_2019_52225_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/e14f7f71dcb2/41598_2019_52225_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/38a62168f759/41598_2019_52225_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/31e38438dbb5/41598_2019_52225_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d41/6825151/b61bb12a7640/41598_2019_52225_Fig6_HTML.jpg

相似文献

1
The Role and Therapeutic Potential of miRNAs in Colorectal Liver Metastasis.miRNAs 在结直肠癌肝转移中的作用和治疗潜力。
Sci Rep. 2019 Nov 1;9(1):15803. doi: 10.1038/s41598-019-52225-2.
2
Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.通过调节成纤维细胞生长因子受体 1 的表达鉴定 microRNA-214 作为结直肠癌肝转移的负调节剂。
Hepatology. 2014 Aug;60(2):598-609. doi: 10.1002/hep.27118. Epub 2014 May 28.
3
microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.microRNA-320a 通过靶向神经纤毛蛋白 1 抑制肿瘤侵袭,与结直肠癌肝转移相关。
Oncol Rep. 2012 Mar;27(3):685-94. doi: 10.3892/or.2011.1561. Epub 2011 Nov 23.
4
Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.miR-17的过表达与结直肠癌肝转移相关。
Medicine (Baltimore). 2020 Feb;99(9):e19265. doi: 10.1097/MD.0000000000019265.
5
Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.通过生物信息学分析和体外实验鉴定结直肠癌肝转移的关键基因和 microRNAs。
Oncol Rep. 2019 Jan;41(1):279-291. doi: 10.3892/or.2018.6840. Epub 2018 Nov 1.
6
miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.微小RNA-99b-5p通过下调雷帕霉素靶蛋白(mTOR)抑制结直肠癌肝转移。
Oncotarget. 2015 Sep 15;6(27):24448-62. doi: 10.18632/oncotarget.4423.
7
Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.差异 miRNA 表达与结直肠癌肝转移和腹膜转移的相关性研究。
BMC Cancer. 2018 Feb 20;18(1):201. doi: 10.1186/s12885-018-4043-0.
8
Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.人类结直肠癌转移特异性微小RNA特征的鉴定
J Natl Cancer Inst. 2015 Feb 6;107(3). doi: 10.1093/jnci/dju492. Print 2015 Mar.
9
Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.鉴定 microRNA-487b 作为结直肠癌中 KRAS 调节的肝转移负调节剂。
Int J Oncol. 2017 Feb;50(2):487-496. doi: 10.3892/ijo.2016.3813. Epub 2016 Dec 20.
10
Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.通过hsa-miR-140-5p介导的Smad2抑制和自噬抑制结肠直肠癌干细胞的存活及侵袭潜能
Oncotarget. 2015 Aug 14;6(23):19735-46. doi: 10.18632/oncotarget.3771.

引用本文的文献

1
The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications.肠道微生物群及其在癌症代谢、发生和进展中的多方面作用:见解与治疗意义
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251331960. doi: 10.1177/15330338251331960. Epub 2025 Apr 10.
2
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy.结直肠癌微环境中的铜:开创基于铜死亡疗法的新时代。
Front Oncol. 2025 Jan 9;14:1522919. doi: 10.3389/fonc.2024.1522919. eCollection 2024.
3
Unique miRNA Expression Profile in MSI- and EMAST-Unstable Sporadic Colon Cancer.

本文引用的文献

1
Disappearing liver metastases: A systematic review of the current evidence.消失的肝转移瘤:当前证据的系统回顾。
Surg Oncol. 2019 Jun;29:7-13. doi: 10.1016/j.suronc.2019.02.005. Epub 2019 Feb 11.
2
Update on systemic therapy for colorectal cancer: biologics take sides.结直肠癌全身治疗的最新进展:生物制剂各有千秋。
Transl Gastroenterol Hepatol. 2019 Feb 13;4:9. doi: 10.21037/tgh.2019.01.12. eCollection 2019.
3
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
微卫星不稳定性和 EMAST 不稳定的散发性结肠癌中的独特 miRNA 表达谱。
Genes (Basel). 2024 Aug 1;15(8):1007. doi: 10.3390/genes15081007.
4
MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma.miR-1976/NCAPH/P65 轴抑制肺腺癌的恶性表型。
Sci Rep. 2024 May 16;14(1):11211. doi: 10.1038/s41598-024-61261-6.
5
[Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].[基因确诊的1型多发性内分泌腺瘤综合征患者及其表型模拟者的血浆微小RNA表达]
Probl Endokrinol (Mosk). 2024 Jan 24;69(6):70-85. doi: 10.14341/probl13357.
6
Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.血清 miR-133b 和 miR-206 下调与转移性结直肠癌患者进展的临床结局相关,可作为监测的生物标志物。
Microrna. 2024;13(1):56-62. doi: 10.2174/0122115366266024240101075745.
7
Rebound increase in microRNA levels at the end of 5-FU-based therapy in colorectal cancer patients.结直肠癌患者接受 5-FU 为基础的治疗结束时微小 RNA 水平的反弹增加。
Sci Rep. 2023 Aug 30;13(1):14237. doi: 10.1038/s41598-023-41030-7.
8
Integrated bioinformatics analysis for novel miRNAs markers and ceRNA network in diabetic retinopathy.糖尿病视网膜病变中新型miRNA标志物及ceRNA网络的综合生物信息学分析
Front Genet. 2022 Sep 16;13:874885. doi: 10.3389/fgene.2022.874885. eCollection 2022.
9
Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis.基于靶标PTEN的miR-425和miR-576作为结直肠癌肝转移潜在诊断和免疫治疗生物标志物的鉴定。
Front Oncol. 2021 Aug 19;11:657984. doi: 10.3389/fonc.2021.657984. eCollection 2021.
10
Evolutions of the Management of Colorectal Cancer Liver Metastasis: A Bibliometric Analysis.结直肠癌肝转移管理的演变:一项文献计量分析
J Cancer. 2021 Apr 30;12(12):3660-3670. doi: 10.7150/jca.52842. eCollection 2021.
TRIB3 通过与β-catenin 和 TCF4 相互作用来增加结直肠癌细胞干细胞的干细胞特征和肿瘤发生。
Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.
4
Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers.甲基化结肠癌细胞中,受表观遗传调控的 miR-1247 通过 MYCBP2 发挥肿瘤抑制作用。
Br J Cancer. 2018 Nov;119(10):1267-1277. doi: 10.1038/s41416-018-0249-9. Epub 2018 Oct 15.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Implication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss diets.miR-612 和 miR-1976 在调节 TP53 和 CD40 中的意义及其在对特定减肥饮食的反应中的关系。
PLoS One. 2018 Aug 8;13(8):e0201217. doi: 10.1371/journal.pone.0201217. eCollection 2018.
7
A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.一个包含六个 microRNA 的标志物可预测子宫内膜癌患者的生存情况。
Curr Probl Cancer. 2019 Apr;43(2):167-176. doi: 10.1016/j.currproblcancer.2018.02.002. Epub 2018 Feb 21.
8
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.微小RNA-378通过抑制SDAD1抑制结肠癌细胞的增殖、迁移和侵袭。
Cell Mol Biol Lett. 2017 Jul 17;22:12. doi: 10.1186/s11658-017-0041-5. eCollection 2017.
9
Colorectal cancer statistics, 2017.结直肠癌统计数据,2017 年。
CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.
10
Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.miR-29a在胰腺癌自噬中的新作用及其治疗潜力。
Oncotarget. 2016 Nov 1;7(44):71635-71650. doi: 10.18632/oncotarget.11928.